2-((1-(2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)-1H-1,2,3-triazol-4-yl)methoxy)-N-(p-tolyl)benzamide

ID: ALA4074079

PubChem CID: 137641162

Max Phase: Preclinical

Molecular Formula: C30H33N5O4

Molecular Weight: 527.63

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(cc1OC)CN(CCn1cc(COc3ccccc3C(=O)Nc3ccc(C)cc3)nn1)CC2

Standard InChI:  InChI=1S/C30H33N5O4/c1-21-8-10-24(11-9-21)31-30(36)26-6-4-5-7-27(26)39-20-25-19-35(33-32-25)15-14-34-13-12-22-16-28(37-2)29(38-3)17-23(22)18-34/h4-11,16-17,19H,12-15,18,20H2,1-3H3,(H,31,36)

Standard InChI Key:  VBZMWGPVWJHSCM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
   10.7624   -4.6183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7612   -5.4420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4734   -5.8510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1872   -5.4415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1844   -4.6147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4716   -4.2053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8997   -5.8490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9010   -6.6703    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.6068   -5.4393    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3192   -5.8468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8947   -4.1993    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.6039   -4.6094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3142   -4.1940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0636   -4.5307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6122   -3.9172    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.1968   -3.2068    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3941   -3.3799    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.4305   -3.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8387   -3.2047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6600   -3.2042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0698   -3.9222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8875   -3.9237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0679   -2.4969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8918   -2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2967   -3.2149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1169   -3.2186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5332   -2.5082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1192   -1.7926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3003   -1.7924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5324   -1.0811    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.3545   -2.5105    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.7611   -3.2235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3537   -1.0816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3159   -6.6666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0275   -7.0781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7397   -6.6642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7358   -5.8387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0236   -5.4349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4490   -7.0701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
  5 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 13  1  0
 15 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 23  1  0
 21 22  1  0
 22 25  1  0
 24 23  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 28 30  1  0
 27 31  1  0
 31 32  1  0
 30 33  1  0
 10 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 10  1  0
 36 39  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4074079

    ---

Associated Targets(Human)

K562/A02 (383 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCB1 Tchem P-glycoprotein 1 (14716 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 527.63Molecular Weight (Monoisotopic): 527.2533AlogP: 4.49#Rotatable Bonds: 10
Polar Surface Area: 90.74Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.14CX LogP: 4.74CX LogD: 4.55
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.32Np Likeness Score: -1.54

References

1. Pan M, Cui J, Jiao L, Ghaleb H, Liao C, Zhou J, Kairuki M, Lin H, Huang W, Qian H..  (2017)  Synthesis and biological evaluation of JL-A7 derivatives as potent ABCB1 inhibitors.,  25  (15): [PMID:28645831] [10.1016/j.bmc.2017.06.015]

Source